Metastatic Breast Cancer: Treatment Options

Name: Advanced Cancer Treatment Centers (ACTC)
Address: 15211 Cortez Blvd., Brooksville, FL, 34613, US
Telephone: 352-345-4565

April 14, 2026

Hearing that you or someone you love has metastatic breast cancer can feel overwhelming. This guide explains what metastatic breast cancer treatment typically involves and how decisions are made over time.

Metastatic breast cancer, also known as stage IV, means the cancer has spread beyond the breast to other parts of the body. Even so, it is still treated as breast cancer, using therapies designed for the original cancer type.

What Does Metastatic Breast Cancer Mean?

Breast cancer occurs when the cells of breast tissue become damaged and reproduce in an uncontrolled fashion. When that cancer grows and spreads to distant organs, including but not limited to bone, lung, and liver tissues, it is called metastatic breast cancer.

Although breast cancer may metastasize to the bone tissue, for example, it is not treated with the same methods as a “bone cancer” or osteosarcoma would be treated. In other words, cancer that starts in the breast is treated as breast cancer, even if it spreads elsewhere.

How Common is Metastatic Breast Cancer?

Excluding skin cancer, breast cancer is the most commonly diagnosed type of malignancy among U.S. women. In 2024, estimates suggest that about 310,720 women will be diagnosed with invasive breast cancer in the U.S., and about 6% of cases are diagnosed with distant (metastatic) disease.

Metastatic breast cancer can happen in two main ways:

Diagnosed at stage IV from the beginning
Develops after earlier-stage treatment

Distant Recurrence and Timing

It’s far more common for metastases to develop several months or years after treatment has been completed. This condition is sometimes called distant recurrence.

Factors that influence distant recurrence include the biological characteristics of the original malignancy, its stage, and the treatment strategy used earlier. These factors help guide what the next treatment may look like.

Treatment Goals and How Plans are Built

Unfortunately, as of this writing, metastatic breast cancer is incurable; treatments are usually staged or combined in “lines” to maximize effectiveness over time. This means therapies may be used one after another or together, depending on how the cancer responds.

Due to the unrelenting nature of the disease, metastatic breast cancer treatment plans focus on creating the highest potential for the longest survival possible, with the fewest side effects, thus encouraging the best quality of life for the patient. The goal is to control the cancer while helping you feel as well as possible.

Many factors will influence the treatment plan for metastatic breast cancer, including:

The type and developmental stage of the original malignancy
Hormone receptor and/or human epidermal growth factor receptor 2 (HER2) status
Where cancer has spread
The genetic characteristics of the cancer cells

Other considerations may include:

Treatment history and outcome
Site-specific symptoms the patient is experiencing

Your oncology team uses this information to tailor treatment to your individual situation.

Hormone Therapy Options

During the diagnosis stage, the hormone receptor status of breast cancer is determined by analyzing a tissue biopsy. Hormone receptor-positive metastatic breast cancer can grow in response to the primary female sex hormones, estrogen and progesterone.

Drugs like tamoxifen, anastrozole, and goserelin are designed either to block the effect of estrogen on cancer cells or to reduce the body’s production of estrogen.

Your oncologist has a few different types of hormone-blocking drugs to choose from, such as aromatase inhibitors (like anastrozole) or SERMs (like tamoxifen). The best choice for your treatment plan will depend on your menopausal status and your past medical history.

Premenopausal women: Therapies that suppress the production of estrogen within the ovaries; in certain cases, removal of the ovaries may also be an option.

Postmenopausal women: Aromatase inhibitors or SERMs may be administered; the specific choice depends on your overall health, cancer characteristics, and previous therapies.

Targeted Therapy Options

When breast cancer spreads, it can affect different tissues and develop unique characteristics. Targeted therapies allow your doctor to create a personalized treatment plan based on the specific traits of your cancer.

Common targeted therapies include:

HER2-targeted antibodies (like trastuzumab or pertuzumab): These therapies specifically seek out and act on cancer cells that produce high levels of the HER2 protein.

CDK4/6 inhibitors (like Abemaciclib, Ribociclib, and Palbociclib): These drugs block the enzymes that signal cancer cells to grow and divide. They are usually combined with hormone therapy (though sometimes used alone) to treat hormone receptor-positive, HER2-negative metastatic breast cancer.

mTOR inhibitors: This is another type of targeted therapy used alongside hormone therapy to help control the spread of hormone receptor-positive, HER2-negative breast cancer.

Chemotherapy Options

When combined with anti-HER2 targeted therapy, chemotherapy may be effective at treating HER2-positive metastatic breast cancer regardless of hormone receptor status.

Chemotherapy may also be considered for hormone receptor-positive metastatic disease, particularly if hormone therapies are no longer effectively controlling the cancer.

If you have any questions or concerns regarding what’s right for you, don’t hesitate to contact us at 352-345-4565 or book an appointment.